Backers of the cancer drug which led to Martha Stewart's downfall plan to try again for federal approval.
ImClone and Bristol-Myers Squibb say they will use new data as they seek to clear Erbitux for U.S. sales. Researchers recently reported Erbitux is effective in shrinking tumors of some colon cancer patients.
If the drug gets approval, it could be on the market by next year. And approval could bring a turnaround for ImClone, the company that developed Erbitux. Its stock price is up.
That's rather late for Stewart, who sold just before a regulatory disapproval that made Imclone's price plunge. The domestic diva wound up in an insider trading scandal, is under indictment, and has resigned as head of her media company.
What's on Tonight
Your Opinion
Follow WTVY
WTVY Hometown Classifieds
No Items Retrieved from Feed.
Wiregrass Photobook
Missing donkey
Sasha
Hunter
Rainbows
Double rainbow in red level al
MY Dads Grave
Upload your images, or browse our other albums.
WTVY-TV
285 N Foster Street
Dothan, AL 36303
334-792-3195
Gray Television, Inc. - Copyright © 2002-2013 - Designed by Gray Digital Media - Powered by Clickability
User Agent: CCBot/2.0 - 370226
